Pricing Log in Create free account

ADMA Biologics Inc (ADMA) vs Aurinia Pharmaceuticals Inc (AUPH)

ADMA Biologics Inc and Aurinia Pharmaceuticals Inc are both Biotechnology companies. ADMA Biologics Inc and Aurinia Pharmaceuticals Inc are of similar size ($2.4B and $2.2B). Aurinia Pharmaceuticals Inc trades at the lower P/E: 6.9× against 14.8×. Aurinia Pharmaceuticals Inc grew revenue faster over the last twelve months: 19.8% against 8.04%. Aurinia Pharmaceuticals Inc has the higher net margin (100.8% vs 33.0%) and the higher return on invested capital (40.8% vs 29.8%). Across the 21 metrics below, Aurinia Pharmaceuticals Inc leads on 16 and ADMA Biologics Inc on 5.

Valuation

Metric ADMA AUPH Biotechnology median
P/E 14.83 6.91 8.50
P/S 4.76 6.89 9.71
P/B 5.97 3.49 2.13
Price to free cash flow 20.97 12.27 20.82
EV/EBITDA 10.74 10.93 0.64
EV/Sales 4.88 5.61 9.21
Earnings yield 6.74% 14.48% (33.15%)
Free cash flow yield 4.77% 8.15% (25.50%)

Profitability

Metric ADMA AUPH Biotechnology median
Gross margin 64.71% 90.36% 65.16%
Operating margin 43.82% 45.15% 0.00%
Net margin 32.98% 100.84% 0.00%
Free cash flow margin 22.69% 56.20% 0.00%
Return on equity 41.90% 66.12% (56.36%)
Return on assets 27.19% 48.52% (48.04%)
Return on invested capital 29.78% 40.76% 0.00%

Growth

Metric ADMA AUPH Biotechnology median
Revenue growth (TTM) 8.04% 19.76% 6.02%
EPS growth (last fiscal year) (25.93%) 5,075.00% 30.26%
Revenue growth, 5-year CAGR 64.60% 41.38% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADMA AUPH Biotechnology median
Debt to equity 0.49 0.07 0.00
Current ratio 6.97 5.42 4.72
Net debt to EBITDA (0.06) (2.58) 0.96

Dividend

Metric ADMA AUPH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADMA AUPH Biotechnology median
Market cap 2.40b 2.23b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack